(PharmaNewsWire.Com, September 11, 2017 ) Rising Chronic disease prevalence and increasing biopharmaceutical investments will propel the growth of the market.
A bioreactor is a manufacture device which supports a biologically active environment. It is a vessel in which a chemical process is taken place which involves organisms or biochemically active substances derived from such organisms. These devices are being developed for use in tissue engineering or biochemical Engineering.
The growth of Bioreactors market is attributed to factors like rising chronic diseases prevalence, increase in incidence of lifestyle diseases like diabetes and cancer, rising biopharmaceutical investments, increasing demand for therapeutically active vaccines, product innovation and favourable governments initiatives to develop healthcare infrastructure. Growing personalized medicine market and increasing popularity for them and increasing popularity of single-use bioreactor among the biopharmaceutical companies will also assist the growth of market. However, regulatory issues regarding single-use bioreactors, limited storage and vulnerability to leaching may hinder the growth of market. Moreover, large scale disposal of plastic derivatives is an environmental concern restraining the growth.
Get a comprehensive overview of the Global Bioreactors Market:
The Global market for Bioreactors is segmented based on Material, Scale, Production Size, Control Type, End Users and Suppliers. Based on Material - Glass, Stainless-Steel and Single use. Based on Scale – 5L-20L, 20L-200L, 200L-1500L and Over 1500L. Based on Production Size – Lab-Scale Production, Pilot-Scale Production, Full-Scale Production. Based on Control Type – Manual and Automated (MFCs). Based on End Users - R&D Departments, R&D Institutes, CRO’s, Biopharmaceutical Companies, Biopharmaceutical Manufacturers and CMO’s. Based on Suppliers - OEMs, System Integrators and EPCs. Based on Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. North America is leading the market while Europe is at second place. Increasing financial support for development of innovative drugs and increase in no. of biopharmaceutical manufacturers has propelled the growth of these markets. Asia Pacific is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness and rapid medical and technological advancements in Asian countries like India and China. CMO’s are the major players in terms of end users. Single-use bioreactors are the most widely used one with 41 % share. Glass bioreactors are majorly used for R&D.
Get accurate market forecast and analysis on the Global Bioreactors Market Request a sample to stay up-to-date on the main trends affecting this market:
Some of the key players dominating this market include Sartorius AG, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, and major Engineering, Procurement and Construction (EPC) players included in this report are Amec Foster Wheeler plc., Fluor Corporation, Jacobs Engineering Group Inc., M+W Group, PM Group, and Technip S.A.
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
